Bal Pharma Limited (NSE:BALPHARMA)
106.20
-2.08 (-1.92%)
Sep 24, 2026, 1:45 PM IST
Bal Pharma Revenue
Bal Pharma had revenue of 886.16M INR in the quarter ending June 30, 2026, with 34.53% growth. This brings the company's revenue in the last twelve months to 3.34B, up 13.51% year-over-year. In the fiscal year ending March 31, 2026, Bal Pharma had annual revenue of 3.12B with 2.83% growth.
Revenue (ttm)
3.34B
Revenue Growth
+13.51%
P/S Ratio
0.51
Revenue / Employee
3.56M
Employees
939
Market Cap
1.72B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 3.12B | 85.78M | 2.83% |
| Mar 31, 2025 | 3.03B | -361.36M | -10.65% |
| Mar 31, 2024 | 3.39B | 350.03M | 11.51% |
| Mar 31, 2023 | 3.04B | 230.02M | 8.18% |
| Mar 31, 2022 | 2.81B | 306.86M | 12.25% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Valiant Laboratories | 3.06B |
| Amanta Healthcare | 2.91B |
| Balaxi Pharmaceuticals | 2.80B |
| Bafna Pharmaceuticals | 1.43B |
| Alpa Laboratories | 1.11B |
| Par Drugs and Chemicals | 1.09B |
| Vaishali Pharma | 1.08B |
| Brooks Laboratories | 831.87M |